logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Kabra Drugs Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524322
    INE323K01017
    3.255251
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    9.67
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
Date Headline
15-Nov-2024 Kabra Drugs reports standalone net loss of Rs 0.40 crore in the September 2024 quarter
08-Nov-2024 Kabra Drugs to convene board meeting
22-Oct-2024 Kabra Drugs to consider Fund Raising
16-Sep-2024 Kabra Drugs to hold AGM
28-Aug-2024 Kabra Drugs to conduct board meeting
16-Aug-2024 Kabra Drugs reports standalone net loss of Rs 0.55 crore in the June 2024 quarter
09-Aug-2024 Kabra Drugs announces board meeting date
12-Jul-2024 Kabra Drugs Ltd - Board Meeting Outcome for Outcome Of The Board Meeting And Disclosure Under Regulation 30 Of SEBI(Listing Obligations & Disclosure Requirements) Regulations 2015
09-Jul-2024 Kabra Drugs to conduct board meeting
06-Jul-2024 Kabra Drugs Ltd - Board Meeting Intimation for Intimation Of Board Meeting
1 2